Closed
SectorHealthcare
267.08 4.76
24h
Min
252.55
Max
267.08
Income | 28M -84M |
---|---|
Sales | 92M 593M |
EPS | 0.06 |
Profit margin | -14.121 |
Employees | 2,230 |
EBITDA | -92M -155M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +26.42% upside |
Next Earnings | 1 May 2025 |
---|
Market Cap | -46M 35B |
---|---|
Previous open | 262.32 |
Previous close | 267.08 |
By Acuity
50%
50%
180 / 386 Healthcare
By Trading Central
Confidence
Bearish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 323.33 USD 26.42%
High 500 USD
Low 206 USD
Based on 22 Wall Street analysts offering 12 month price targets forAlnylam Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$